Novel and recurrent histopathologic patterns of mogamulizumab‐associated rash: diagnostic implications and insights for accurate diagnosis
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2025
DOI: 10.1111/ddg.15773 ↗Kurz gefasst
Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2025. Verfasst von Christina Mitteldorf. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, University Medical Centre Göttingen, Göttingen, Germany. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Drug Eruptions, Exanthema. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Mogamulizumab‐associated rash (MAR) is a frequent side‐effect of a treatment with Mogamulizumab that poses diagnostic challenges. Patients and methods We reviewed our database for novel histological patterns in MAR.
Results
Four new histological patterns were identified: (1) A pagetoid pattern, which could be mistaken for CD8 + aggressive epidermotropic cytotoxic T‐cell lymphoma. (2) A lupus erythematosus‐like pattern, characterized vacuolar interface dermatitis, deep perivascular lymphocytic infiltrate, interstitial mucin deposits, and clusters of CD123 + plasmacytoid dendritic cells. (3) Pustular folliculitis/acneiform pattern, which may clinically and histologically resemble acne. (4) A combined pattern with MAR coexisting with residual or new infiltrates of the original/underlying lymphoma. Previously described main patterns were reproducible. The folliculotropic and MF‐like epidermotropic infiltrate should be also mentioned as separate patterns. Immunohistochemistry and the comparison with the original lymphoma remain crucial for diagnosis, especially a shift towards CD8 + cells, CD7 expression by infiltrating lymphocytes, and an increased number of histiocytes across all MAR patterns.
Conclusions
MAR presents a range of histological patterns that mimic other conditions, underscoring the importance of careful histopathological and immunohistochemical analysis and clinicopathological correlation for accurate diagnosis and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Allergology, University Medical Centre Göttingen, Göttingen, Germany.
ORCID-Profile: Christina Mitteldorf
Zitieren
APA
Mitteldorf, C. (2025). Novel and recurrent histopathologic patterns of mogamulizumab‐associated rash: diagnostic implications and insights for accurate diagnosis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15773
Vancouver
Mitteldorf C. Novel and recurrent histopathologic patterns of mogamulizumab‐associated rash: diagnostic implications and insights for accurate diagnosis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2025. doi:10.1111/ddg.15773
BibTeX
@article{Mitteldorf2025,
author = {Mitteldorf, Christina},
title = {Novel and recurrent histopathologic patterns of mogamulizumab‐associated rash: diagnostic implications and insights for accurate diagnosis},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2025},
doi = {10.1111/ddg.15773}
}
EUVIMED